Reference
Pinto H, et al. Minimal change disease with maximum immunosuppression: Successful treatment of steroid-dependent minimal change disease with rituximab. BMJ Case Reports 2018: 05 Feb 2018. Available from: URL: http://doi.org/10.1136/bcr-2017-223407 - Portugal
Rights and permissions
About this article
Cite this article
Deflazacort. Reactions Weekly 1695, 152 (2018). https://doi.org/10.1007/s40278-018-43979-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-43979-8